HTLV-I infection was also inhibited by treatment with C2-, C3-, C6-, or C9-deficient serum, but not by C1q-deficient serum. Inhibitory activities of normal human serum against HTLV-I were neutralized by anti-C1q serum. Furthermore, purified C1q inhibited HTLV-I infection. The direct ...
PURPOSE:To obtain a pharmaceutical preparation containing an anti-HTLV-I antibody-positive immunoglobulin as an active ingredient and capable of preventing infection by administering after chance infected by HTLV-I. CONSTITUTION:The objective infection preventing agent containing anti-HTLV-I antibody-...
Human T-lymphotrophic virus type I (HTLV-I) is an oncogenic retrovirus and its infection is associated with a variety of human diseases including HTLV-I-associated myelopathy/tropic spastic paraparesis (HAM/TSP). Large numbers of epidemiological, virological, immunological, and clinical studies on H...
Almost a quarter of a century ago, Oldstone and colleagues proposed that infection of cells by noncytopathic viruses may lead to an alteration of the cells’ ability to produce certain products or perform certain tasks, i.e., inhibition of "luxury function." In this issue of the JCI, this...
HTLV-I infection is endemic in certain parts of the Natal/KwaZulu region of South Africa. No studies on the seroprevalence of HTLV-I infection in the Free State (FS) have been published. This study was designed to determine the prevalence of HTLV-I antibodies among different patient groups ...
Introduction: Human T cell Lymphotropic Virus Type 1 (HTLV-I) infection has been recognized as the causative agents of two diseases; HTLV-1- associated myelopathy tropical spastic paraparesis (HAMITSP) and adult T- cell leukemia (ATL). A... Hossini,J Ghafari,S Miri,... - 《Medical Journ...
The clinical entity of adult T-cell leukemia (ATL) was established around 1977, and human T-cell leukemia virus type 1 (HTLV-I) was subsequently identified in 1980. In the 25 years since the discovery of HTLV-I, HTLV-I infection and its associated diseas
The protective effect of purified human immunoglobulin against human T-cell leukaemia virus type I (HTLV-I), designated ATLIG on HTLV-I infection was examined in cynomolgus monkeys (Macaca fascicularis) as a preclinical study. Passive immunization of ATLIG 24 h before challenging HTLV-I protected...
The high rate of HTLV-II infection among IDUs is consistent with the previously reported prevalence among Stephanie H. Factor Department of Internal Medicine; Columbia-Presbyterian Medical Center; New York, NY, U.S.A. Kathleen L. Irwin; Renu B. Lal; Donna Rudolph; J. Todd Weber Cen...
Erectile dysfunction and HTLV-I infection: a silent problem. Int J Impot Res ... N Castro,P Oliveira,D Freitas,... - 《International Journal of Impotence Research》 被引量: 24发表: 2016年 Clinical Manifestations Associated with HTLV Type I Infection: A Cross-Sectional Study Human T-...